Headquartered in Melville, NY Fiscal year ends December NASDAQ: HSIC henryschein.com
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company serving healthcare customers. With more than 25,000 employees worldwide, the company provides more than 1 million customers globally with over 300 solutions designed to improve operational success and clinical outcomes. Its business, clinical, technology, and supply chain solutions serve office-based dental and medical practitioners, dental laboratories, government and institutional healthcare clinics, and alternate care sites. The company operates through a centralized and automated distribution network offering more than 300,000 branded and corporate brand products. Henry Schein is a FORTUNE 500 Company and S&P 500 member with operations or affiliates in 34 countries and territories, and reported 2025 sales of $13.2 billion. The company's segments include Global Distribution and Value-Added Services (dental merchandise, dental equipment, medical distribution, and value-added services), Global Specialty Products, and Global Technology. Updated
Pre-Market Stock Futures: Futures are trading higher after a dreadful day on Wall Street, when all the major indices traded lower, and we saw the same pattern that has developed over the…
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company serving healthcare customers. With more than 25,000 employees worldwide, the company provides more than 1 million customers globally with over 300 solutions designed to improve operational success and clinical outcomes.
24/7 Wall St.'s 12-month price target for HSIC is $109.17, rated Buy. The Wall Street consensus target is $97.27. HSIC price prediction →
